How On-Campus MOB Financing Works in Boston
Boston occupies a singular position in the national medical office market. The concentration of globally recognized academic medical systems, including Mass General Brigham, Beth Israel Deaconess Medical Center, and Dana-Farber Cancer Institute, creates a foundation of institutional healthcare demand that few metros can replicate. On-campus medical office buildings in Boston are not simply a real estate asset class. They are infrastructure for some of the most mission-critical outpatient and specialty care delivery in the country, and lenders price them accordingly.
The most competitive financing in this program type concentrates around the Longwood Medical Area, the Back Bay medical corridor, and affiliated campus properties in Cambridge. These assets are typically anchored by hospital-employed physician groups, imaging and diagnostic services, and outpatient surgery centers operating under long-term NNN leases with health system guaranties. Occupancy in these core locations consistently exceeds 95 percent, and replacement supply is severely constrained by land scarcity and construction costs that remain among the highest in the country. That supply-demand imbalance underpins lender conviction and keeps capital flowing aggressively to well-structured deals.
Suburban nodes including Waltham, Quincy, Braintree, Burlington, and Peabody represent a secondary tier of Boston MOB activity. These submarkets attract health system-affiliated tenants seeking lower-cost locations for high-volume outpatient services. Financing for suburban on-campus and campus-adjacent assets follows similar structural logic, though lender pricing and leverage tolerances reflect slightly more distance from the institutional core. Strong population density and limited competing supply in these corridors continue to support solid lender sentiment on stabilized, credit-tenanted product.
Lender Appetite and Capital Stack for Boston On-Campus MOB
Life insurance companies are the dominant and most competitive capital source for stabilized on-campus MOB in Boston. For assets anchored by investment-grade or near-investment-grade health systems under long-term NNN leases, life companies are pricing in a range of approximately 125 to 175 basis points over the 10-year Treasury. With the 10-year Treasury around 4.3 percent in early 2026, all-in fixed rates on the best-qualified transactions fall in a range that remains attractive relative to recent history. Life companies typically lend at 60 to 70 percent LTV, with 25 to 30 year amortization schedules, and structure prepayment through yield maintenance or a declining schedule. This structure rewards sponsors with long hold horizons and strong credit tenancy who are not prioritizing near-term exit flexibility.
CMBS is an active alternative for on-campus Boston deals at 10 million dollars and above where health system credit is investment-grade or near-investment-grade. CMBS pricing runs approximately 175 to 250 basis points over, with leverage available in the 65 to 75 percent LTV range. The tradeoff is defeasance as the standard prepayment mechanism, which limits flexibility for sponsors anticipating a disposition or refinance event before loan maturity. CMBS executes well on larger portfolio or campus transactions where fixed-rate, non-recourse structure is the priority and the sponsor has cleared diligence on all tenants and lease structures.
Bridge financing through debt funds or regional banks including Eastern Bank and Rockland Trust addresses lease-up, renovation, or transitional situations ahead of a permanent takeout. Debt fund floating-rate pricing typically runs 150 to 250 basis points over SOFR, which with SOFR around 3.6 percent in early 2026 produces all-in rates in a range that reflects the transitional risk being underwritten. Regional banks are competitive on smaller balance deals with established sponsorship relationships, often providing construction or lease-up capital with a path to permanent financing once stabilization is achieved.
Underwriting Criteria That Matter in Boston
Lender underwriting for on-campus Boston MOB centers on three variables above all others: tenant credit quality, lease structure, and the criticality of the facility to the health system's care delivery model. An investment-grade health system guaranty on a 15-year NNN lease for a campus-integrated imaging or surgical facility will move through life company credit faster and at tighter pricing than a multi-tenant building with physician group leases lacking system-level credit support. Lenders are explicit about this distinction, and sponsors should not assume the on-campus location alone is sufficient to achieve the tightest pricing tier.
Building specifications matter more in Boston than in many markets because tenants here are sophisticated health systems with technical requirements. Medical-grade HVAC, reinforced floors for imaging equipment, hospital-level electrical capacity, and ADA compliance throughout are baseline expectations rather than competitive differentiators. Lenders will commission detailed physical due diligence reports and will scrutinize deferred maintenance on any asset with a building vintage older than 15 years. In a market where construction costs are as high as they are in Boston, replacement cost analysis consistently supports valuations on well-maintained stabilized assets, which benefits sponsors seeking to maximize proceeds.
Lease rollover concentration within the loan term is a primary credit concern. Boston life company lenders and CMBS conduits will stress scenarios where a single major tenant does not renew, and they underwrite to that outcome conservatively. Deals where a health system anchor's lease expiration falls within the loan term require either a lease extension executed prior to closing or explicit structural mitigants such as cash flow reserves or partial recourse during the rollover window.
Typical Deal Profile and Timeline
A representative on-campus MOB financing in Boston involves a stabilized asset in the Longwood Medical Area or a campus-adjacent property in a suburban node like Waltham or Burlington, with a total loan request in the 20 to 75 million dollar range. The sponsor is typically an institutional healthcare real estate investor, a regional developer with a long-standing health system relationship, or a private equity platform with an existing MOB portfolio seeking permanent fixed-rate capital. Lenders in this program expect experienced medical office sponsorship with verifiable asset management capability. First-time healthcare real estate buyers without an experienced operating partner will face a higher bar.
Timeline from signed LOI to closing runs approximately 60 to 90 days for life company execution on a clean stabilized deal, assuming all lease documentation, environmental reports, and property condition assessments are assembled efficiently. CMBS executes on a similar timeline but carries more process complexity in the securitization pipeline. Delays most commonly originate from incomplete lease abstracts, tenant estoppel coordination with health system legal teams, or title issues specific to parcels with hospital campus easements or shared infrastructure agreements. Sponsors should engage counsel with healthcare real estate experience early in the process.
Common Execution Pitfalls Specific to Boston
The first and most common pitfall is underestimating the complexity of health system legal review. Major Boston health systems have in-house real estate and legal teams that move on institutional timelines. Estoppel certificates and subordination agreements that take two weeks in other markets can take six to eight weeks in Boston, and lenders will not close without them. Sponsors who have not accounted for this in their closing timeline frequently find themselves managing rate lock extensions at cost.
The second pitfall is assuming on-campus location automatically qualifies a deal for life company execution. Lenders differentiate sharply between true on-campus assets with health system credit and buildings that are simply nearby with physician group tenants who lack system-level lease guaranties. The pricing and leverage differential between these two scenarios is meaningful, and sponsors who have modeled returns based on life company terms before confirming tenant credit structure routinely have to reprice their deals.
The third pitfall is land encumbrance and title complexity. A meaningful share of Boston hospital campus parcels carry easements, air rights agreements, or ground lease structures tied to academic medical institution ownership. These arrangements require specialized title resolution and can slow or complicate financing. Lenders will require full title clarity before issuing a commitment, and sponsors who have not conducted a thorough title review prior to LOI will absorb unexpected time and legal costs.
The fourth pitfall is construction cost exposure on any value-add or renovation component embedded in a deal. Boston construction costs are among the highest in the country. Sponsors who underwrite renovation budgets based on national benchmarks rather than local contractor bids routinely discover budget gaps that affect loan sizing and project returns. Lenders are aware of this dynamic and will haircut renovation cost estimates that are not supported by local contractor pricing.
If you have an on-campus MOB deal under contract or a campus asset in predevelopment in the Boston metro, CLS CRE has the lender relationships and medical office execution experience to structure your capital stack efficiently. Contact Trevor Damyan to discuss your transaction. Our full program guide for on-campus MOB financing covers lender matrices, underwriting benchmarks, and deal structure options across all major markets nationally.